We are live on ! Find out more
BFRIW icon

Biofrontera

6 hedge funds and large institutions have $4.67K invested in Biofrontera in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.1% less ownership

Funds ownership: 4.01%3.91% (-0.1%)

36% less capital invested

Capital invested by funds: $7.27K → $4.67K (-$2.59K)

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$465
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$4.16K
CS
2
Clear Street
New York
$324 +$4 +100 +0.9%
UBS Group
3
UBS Group
Switzerland
$145 +$233 +6,314 +63,140%
US Bancorp
4
US Bancorp
Minnesota
$23
Osaic Holdings
5
Osaic Holdings
Arizona
$22
Bank of America
6
Bank of America
North Carolina
$2 +$4 +100 New
Citadel Advisors
7
Citadel Advisors
Florida
-$465 -11,617 Closed

BFRIW Hedge Fund Activity: Q3 2024 in Review

6 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q3 2024, worth a combined $4.67K — down 36% from $7.27K a quarter earlier.

Fund positioning in BFRIW was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $233. The largest seller was Citadel Advisors, exiting entirely with an estimated $465 sold.

  • 6 institutional investors held Biofrontera (BFRIW) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $4.67K of Biofrontera stock for Q3 2024, down 36% quarter-over-quarter.
  • 1 fund opened new Biofrontera positions in Q3 2024 and 1 closed out, a net change of 0 holders.
  • The largest Biofrontera buyer in Q3 2024 was UBS Group, an estimated $233 added.
  • The largest Biofrontera seller in Q3 2024 was Citadel Advisors, an estimated $465 sold.

Based on aggregated 13F filings for Q3 2024.